Scholarlink

Hypertension is the leading cause of death in the cardiovascular system. Untreated hypertension can affect one’s general health, however medicine can help hypertensive patients to lower their risk of having high blood pressure. Indeed, secondary hypertension remains an unresolved illness. Areas covered: This article will propose a device-based therapy for resistant hypertension that has emerged in recent years. Further to that, the innovations developed in device-based RH treatment will be covered, as well as the research and studies assessing this novel device. Expert opinion: The innovative device-based techniques that target resistant hypertension provide a potential therapy that has been backed by several studies and clinical trials, whereas pharmacological non-adherence and increased sympathetic activity are recognized to be the primary causes of resistant hypertension. Nevertheless, some limitations will be critical for the future of these RH systems, with the device’s design and larger RCTs playing a significant role in determining whether a position in routine treatment could be warranted.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Emerging Device-Based Therapies for Resistant Hypertension: A Critical Appraisal of Clinical Trial Data

  • 会议论文

  • 发表日期：

    2025年

查看全文
  • Zaki Mohamed,
  • Jami Oussama,
  • El Allam Oussama,
  • El Allam Asmaa,
  • Mohamed Hamlich,
  • Najib Alidrissi,
  • Omari Kamal,
  • Imai Soulaymane,
  • Mahmoudi Najib,
  • Bakkali Abderrahmane,
  • Ettahir Aziz,
  • Adnane Benmoussa,
  • Fadil Bakkali

摘要

Hypertension is the leading cause of death in the cardiovascular system. Untreated hypertension can affect one’s general health, however medicine can help hypertensive patients to lower their risk of having high blood pressure. Indeed, secondary hypertension remains an unresolved illness. Areas covered: This article will propose a device-based therapy for resistant hypertension that has emerged in recent years. Further to that, the innovations developed in device-based RH treatment will be covered, as well as the research and studies assessing this novel device. Expert opinion: The innovative device-based techniques that target resistant hypertension provide a potential therapy that has been backed by several studies and clinical trials, whereas pharmacological non-adherence and increased sympathetic activity are recognized to be the primary causes of resistant hypertension. Nevertheless, some limitations will be critical for the future of these RH systems, with the device’s design and larger RCTs playing a significant role in determining whether a position in routine treatment could be warranted.